
Reset all filters
01 3Accord healthcare
02 1Acino Pharma (Pty) Ltd
03 4Acorda Therapeutics
04 1Actavis Inc
05 1Alkem Laboratories
06 1Ascent Innovative Medicines
07 1Aurobindo Pharma Limited
08 1Aurovitas Spain, Sau
09 4Biogen
10 1CinnaGen
11 1Desitin Arzneimittel
12 1Hikma Pharmaceuticals
13 1Intas Pharmaceuticals
14 1Medical Valley
15 2Merz Pharma
16 1Micro Labs Limited
17 2Neuraxpharm
18 1Newbury Pharmaceuticals Ab
19 2ORIFARM GROUP AS
20 1Pharmascience Inc.
21 1Rising Pharmaceuticals Inc
22 3STADA Arzneimittel
23 2Sandoz B2B
24 2Sun Pharmaceutical Industries Limited
25 1Taro Pharmaceutical Industries
26 2Teva Pharmaceutical Industries
27 1Zentiva
Reset all filters
01 6Depot tablet
02 1ER Tablet
03 1Extended Release Tablet
04 10Extended-Release Tablet
05 1SR Tablet
06 1TAB
07 3TABLET (EXTENDED-RELEASE)
08 10TABLET, EXTENDED RELEASE;ORAL
09 9Tablet
10 1Tablet ER.
Reset all filters
01 1Allowed
02 8Approved
03 9Authorized
04 1Cancelled
05 3DISCN
06 1Deregistered
07 1Originator
08 3Prescription
09 6RX
10 10Blank
Reset all filters
01 1AMPYRA
02 9DALFAMPRIDINE
03 1Dalfyra
04 1FAMPYRA
05 1Fampridin Medical Valley
06 1Fampridin Neuraxpharm
07 1Fampridin Zentiva
08 1Fampridina Accord
09 1Fampridina Aurovitas
10 1Fampridina Desitin
11 1Fampridina Sun
12 1Fampridina Teva
13 1Fampridine Accord
14 1Fampridine Newbury
15 1Fampridine Qualigen
16 2Fampridine Sandoz
17 2Fampridine Stada
18 1Fampridine Stada Arzneimittel Ag
19 11Fampyra
20 1PMS-FAMPRIDINE
21 1TARO-FAMPRIDINE
22 2Blank
Reset all filters
01 3Canada
02 2India
03 1Iran
04 6Norway
05 1South Africa
06 10Spain
07 9Sweden
08 1Switzerland
09 10USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DALFAMPRIDINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2018-07-11
Application Number : 206863
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DALFAMPRIDINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2017-01-23
Application Number : 206836
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DALFAMPRIDINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2018-07-30
Application Number : 206765
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : ER Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : DALFAMPRIDINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2017-01-23
Application Number : 206811
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Fampyra
Dosage Form : Depot tablet
Dosage Strength : 10 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Fampyra
Dosage Form : Depot tablet
Dosage Strength : 10 mg
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Fampyra
Dosage Form : Depot tablet
Dosage Strength : 10 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Fampyra
Dosage Form : Depot tablet
Dosage Strength : 10 mg
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Iran
Brand Name : Dalfyra
Dosage Form : Tablet ER.
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DALFAMPRIDINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2018-10-24
Application Number : 206646
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : SR Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Fampridin Medical Valley
Dosage Form : Tablet
Dosage Strength : 10mg
Packaging :
Approval Date : 01/09/2022
Application Number : 20190726000034
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
Brand Name : AMPYRA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2010-01-22
Application Number : 22250
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DALFAMPRIDINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-03-11
Application Number : 210158
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Fampyra
Dosage Form : Depot tablet
Dosage Strength : 10 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Fampyra
Dosage Form : Depot tablet
Dosage Strength : 10 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DALFAMPRIDINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2020-07-06
Application Number : 206858
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DALFAMPRIDINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-05-21
Application Number : 208292
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DALFAMPRIDINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 206854
Regulatory Info :
Registration Country : USA